Crossmark Global Holdings’s AngioDynamics ANGO Stock Holding History

Crossmark Global Holdings’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,800	Closed	-$273K	–	1396
2019 Q3	$273K	Hold	14,800	–	–	0.01%	1105
2019 Q2	$291K	Buy	14,800 +4	+0%	+$81	0.01%	1118
2019 Q1	$338K	Sell	14,796 -80	-0.5%	-$1.74K	0.01%	1061
2018 Q4	$299K	Buy	14,876 +4,510	+44%	+$93.3K	0.01%	1079
2018 Q3	$225K	Buy	10,366 +1,150	+12%	+$25.5K	0.01%	1489
2018 Q2	$205K	Buy	+9,216	New	+$188K	0.01%	1526
2018 Q1	–	Sell	-10,352	Closed	-$172K	–	1578
2017 Q4	$172K	Buy	+10,352	New	+$177K	﹤0.01%	1604

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Crossmark Global Holdings's ANGO Position: Q4 2019 in Review

Crossmark Global Holdings sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 14,800 shares — an estimated $273K sold.

Crossmark Global Holdings first reported a position in ANGO in Q4 2017 and held it in 7 quarters. The position peaked at $338K in Q1 2019. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

Crossmark Global Holdings reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
Crossmark Global Holdings sold 14,800 AngioDynamics shares in Q4 2019, an estimated $273K.
Crossmark Global Holdings first reported a position in AngioDynamics in Q4 2017 and held it in 7 quarters.
Crossmark Global Holdings's AngioDynamics position peaked at $338K in Q1 2019.
157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Crossmark Global Holdings's 13F filing for Q4 2019, filed 6 Feb 2020.